A Massive Charge for Ford, and the CEO of a Biotech Up Nearly 500% this Year 12/15/25
CNBC's "Fast Money"
00:00
Biotech Surge: Terns' Promising CML Data
Amy Burroughs discusses Terns' TRN-701 trial results, plans for pivotal trials, and $750M raise to support development.
Play episode from 36:49
Transcript
